Pancreatic Cancer Research

ResearcherKobe University HospitalNo recent work listed

Takashi Aoi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3963-5922; OpenAlex author ID A5063237654. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase. Last author DOI 10.1186/s12935-023-02928-4↗
  2. Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma. Last author DOI 10.1371/journal.pone.0266620↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kohei Yamakawa · 2 shared papers, 2022–2023 · strength 0.36
  2. Yuzo Kodama · 2 shared papers, 2022–2023 · strength 0.36
  3. Akihito Machinaga · 1 shared paper, 2023 · strength 0.20
  4. Hiroaki Yanagimoto · 1 shared paper, 2022 · strength 0.16
  5. Atsuhiro Masuda · 1 shared paper, 2022 · strength 0.16
  6. Hirochika Toyama · 1 shared paper, 2022 · strength 0.16
  7. Takumi Fukumoto · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.